|
Index of reports
> Cases with Upper Respiratory Tract Infection (4)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Kerlone (Betaxolol) where reactions include upper respiratory tract infection. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Kerlone side effects in female
Reported by a consumer/non-health professional from United States on 2011-10-27
Patient: female, weighing 81.7 kg (179.6 pounds)
Reactions: Wrong Technique in Drug Usage Process, Osteoporosis, Fear, Adverse Drug Reaction, Overdose, Fatigue, Medication Error, Upper Respiratory Tract Infection, Abnormal Loss of Weight, Depression, Kidney Infection, Nervousness, Decreased Appetite, Product Quality Issue, Psychomotor Hyperactivity, Abnormal Behaviour, Tremor, Convulsion, Anxiety, Arthralgia, Heart Rate Increased, Insomnia, Disturbance in Attention, DRY Eye, Asthenia, Feeling Abnormal, Accidental Exposure
Drug(s) suspected as cause:
Celexa
Indication: Product Used FOR Unknown Indication
Kerlone
Indication: Product Used FOR Unknown Indication
Start date: 2001-01-26
Topamax
Administration route: Oral
Start date: 2011-08-22
Topamax
Administration route: Oral
Start date: 2011-08-22
Topamax
Administration route: Oral
Start date: 2011-07-01
Topamax
Administration route: Oral
Start date: 2011-07-01
Topamax
Administration route: Oral
Indication: Migraine
Topamax
Administration route: Oral
Start date: 2011-06-27
End date: 2011-07-01
Topamax
Administration route: Oral
Start date: 2001-01-26
Topamax
Administration route: Oral
Start date: 2011-06-27
End date: 2011-07-01
Topamax
Administration route: Oral
Indication: Convulsion
Topamax
Administration route: Oral
Start date: 2001-01-26
Topiramate
Administration route: Oral
Topiramate
Administration route: Oral
Start date: 2008-01-01
Topiramate
Administration route: Oral
Start date: 2011-01-01
End date: 2011-06-27
Topiramate
Administration route: Oral
Indication: Convulsion
Start date: 2008-01-01
Topiramate
Administration route: Oral
Indication: Migraine Prophylaxis
Topiramate
Administration route: Oral
Topiramate
Administration route: Oral
Indication: Migraine
Topiramate
Administration route: Oral
Start date: 2011-01-01
End date: 2011-06-27
Topiramate
Administration route: Oral
Indication: Migraine
Start date: 2008-01-01
Topiramate
Administration route: Oral
Start date: 2005-01-01
End date: 2011-01-01
Topiramate
Administration route: Oral
Start date: 2008-01-01
Topiramate
Administration route: Oral
Start date: 2005-01-01
End date: 2011-01-01
Topiramate
Administration route: Oral
Indication: Epilepsy
Start date: 2008-01-01
Topiramate
Administration route: Oral
Topiramate
Administration route: Oral
Topiramate
Administration route: Oral
Start date: 2005-01-01
End date: 2011-01-01
Topiramate
Administration route: Oral
Start date: 2011-01-01
End date: 2011-06-27
Trazodone Hydrochloride
Indication: Product Used FOR Unknown Indication
Start date: 2008-01-01
Unknown Medication
Indication: Product Used FOR Unknown Indication
Possible Kerlone side effects in female
Reported by a consumer/non-health professional from United States on 2011-10-19
Patient: female, weighing 81.7 kg (179.6 pounds)
Reactions: Wrong Technique in Drug Usage Process, Adverse Drug Reaction, Fear, Fatigue, Overdose, Upper Respiratory Tract Infection, Medication Error, Abnormal Loss of Weight, Nervousness, Decreased Appetite, Product Quality Issue, Psychomotor Hyperactivity, Convulsion, Tremor, Anxiety, Arthralgia, Heart Rate Increased, Insomnia, Disturbance in Attention, Asthenia, Feeling Abnormal, Accidental Exposure
Drug(s) suspected as cause:
Celexa
Indication: Product Used FOR Unknown Indication
Kerlone
Indication: Product Used FOR Unknown Indication
Start date: 2001-01-26
Topamax
Administration route: Oral
Indication: Convulsion
Start date: 2001-01-26
Topamax
Administration route: Oral
Start date: 2011-08-22
Topamax
Administration route: Oral
Topamax
Administration route: Oral
Topamax
Administration route: Oral
Start date: 2011-06-27
End date: 2011-07-01
Topamax
Administration route: Oral
Start date: 2011-07-01
Topamax
Administration route: Oral
Start date: 2011-06-27
End date: 2011-07-01
Topamax
Administration route: Oral
Start date: 2001-01-26
Topamax
Administration route: Oral
Indication: Migraine
Start date: 2011-08-22
Topamax
Administration route: Oral
Start date: 2011-07-01
Topiramate
Administration route: Oral
Indication: Migraine Prophylaxis
Start date: 2008-01-01
Topiramate
Administration route: Oral
Start date: 2011-01-01
End date: 2011-06-27
Topiramate
Administration route: Oral
Indication: Migraine
Start date: 2008-01-01
Topiramate
Administration route: Oral
Start date: 2005-01-01
End date: 2011-01-01
Topiramate
Administration route: Oral
Start date: 2008-01-01
Topiramate
Administration route: Oral
Start date: 2005-01-01
End date: 2011-01-01
Topiramate
Administration route: Oral
Start date: 2008-01-01
Topiramate
Administration route: Oral
Indication: Epilepsy
Start date: 2008-01-01
Topiramate
Administration route: Oral
Indication: Convulsion
Start date: 2005-01-01
End date: 2011-01-01
Topiramate
Administration route: Oral
Indication: Migraine
Start date: 2011-01-01
End date: 2011-06-27
Topiramate
Administration route: Oral
Start date: 2011-01-01
End date: 2011-06-27
Trazodone Hydrochloride
Indication: Product Used FOR Unknown Indication
Start date: 2008-01-01
Unknown Medication
Indication: Product Used FOR Unknown Indication
Possible Kerlone side effects in female
Reported by a consumer/non-health professional from United States on 2011-10-11
Patient: female, weighing 81.7 kg (179.6 pounds)
Reactions: Wrong Technique in Drug Usage Process, Adverse Drug Reaction, Fear, Overdose, Fatigue, Medication Error, Upper Respiratory Tract Infection, Abnormal Loss of Weight, Decreased Appetite, Nervousness, Product Quality Issue, Psychomotor Hyperactivity, Convulsion, Tremor, Anxiety, Arthralgia, Insomnia, Heart Rate Increased, Disturbance in Attention, Asthenia, Feeling Abnormal, Accidental Exposure
Drug(s) suspected as cause:
Celexa
Indication: Product Used FOR Unknown Indication
Kerlone
Indication: Product Used FOR Unknown Indication
Start date: 2001-01-26
Topamax
Administration route: Oral
Start date: 2011-07-01
Topamax
Administration route: Oral
Topamax
Administration route: Oral
Start date: 2011-08-22
Topamax
Administration route: Oral
Topamax
Administration route: Oral
Start date: 2001-01-26
Topamax
Administration route: Oral
Indication: Migraine
Start date: 2011-08-22
Topamax
Administration route: Oral
Start date: 2011-07-01
Topamax
Administration route: Oral
Start date: 2011-06-27
End date: 2011-07-01
Topamax
Administration route: Oral
Start date: 2011-06-27
End date: 2011-07-01
Topamax
Administration route: Oral
Indication: Convulsion
Start date: 2001-01-26
Topiramate
Administration route: Oral
Indication: Migraine
Start date: 2011-01-01
End date: 2011-06-27
Topiramate
Administration route: Oral
Start date: 2008-01-01
Topiramate
Administration route: Oral
Start date: 2011-01-01
End date: 2011-06-27
Topiramate
Administration route: Oral
Start date: 2011-01-01
End date: 2011-06-27
Topiramate
Administration route: Oral
Indication: Migraine
Start date: 2008-01-01
Topiramate
Administration route: Oral
Start date: 2005-01-01
End date: 2011-01-01
Topiramate
Administration route: Oral
Start date: 2008-01-01
Topiramate
Administration route: Oral
Indication: Migraine Prophylaxis
Start date: 2008-01-01
Topiramate
Administration route: Oral
Start date: 2005-01-01
End date: 2011-01-01
Topiramate
Administration route: Oral
Indication: Convulsion
Start date: 2005-01-01
End date: 2011-01-01
Topiramate
Administration route: Oral
Indication: Epilepsy
Start date: 2008-01-01
Trazodone Hydrochloride
Indication: Product Used FOR Unknown Indication
Start date: 2008-01-01
Unknown Medication
Indication: Product Used FOR Unknown Indication
Possible Kerlone side effects in female
Reported by a consumer/non-health professional from United States on 2011-10-10
Patient: female, weighing 81.7 kg (179.6 pounds)
Reactions: Wrong Technique in Drug Usage Process, Fear, Adverse Drug Reaction, Fatigue, Overdose, Upper Respiratory Tract Infection, Medication Error, Abnormal Loss of Weight, Nervousness, Decreased Appetite, Product Quality Issue, Psychomotor Hyperactivity, Convulsion, Tremor, Anxiety, Arthralgia, Heart Rate Increased, Insomnia, Disturbance in Attention, Asthenia, Feeling Abnormal, Accidental Exposure
Drug(s) suspected as cause:
Celexa
Indication: Product Used FOR Unknown Indication
Kerlone
Indication: Product Used FOR Unknown Indication
Start date: 2001-01-26
Topamax
Administration route: Oral
Indication: Convulsion
Start date: 2001-01-26
Topamax
Administration route: Oral
Start date: 2011-06-27
End date: 2011-07-01
Topamax
Administration route: Oral
Indication: Migraine
Start date: 2011-08-22
Topamax
Administration route: Oral
Topamax
Administration route: Oral
Start date: 2011-07-01
Topamax
Administration route: Oral
Start date: 2001-01-26
Topamax
Administration route: Oral
Start date: 2011-08-22
Topamax
Administration route: Oral
Start date: 2011-06-27
End date: 2011-07-01
Topamax
Administration route: Oral
Start date: 2011-07-01
Topamax
Administration route: Oral
Topiramate
Administration route: Oral
Start date: 2011-01-01
End date: 2011-06-27
Topiramate
Administration route: Oral
Start date: 2005-01-01
End date: 2011-01-01
Topiramate
Administration route: Oral
Start date: 2011-01-01
End date: 2011-06-27
Topiramate
Administration route: Oral
Start date: 2008-01-01
Topiramate
Administration route: Oral
Indication: Migraine Prophylaxis
Start date: 2008-01-01
Topiramate
Administration route: Oral
Indication: Migraine
Start date: 2011-01-01
End date: 2011-06-27
Topiramate
Administration route: Oral
Indication: Epilepsy
Start date: 2008-01-01
Topiramate
Administration route: Oral
Indication: Migraine
Start date: 2008-01-01
Topiramate
Administration route: Oral
Indication: Convulsion
Start date: 2005-01-01
End date: 2011-01-01
Topiramate
Administration route: Oral
Start date: 2008-01-01
Topiramate
Administration route: Oral
Start date: 2005-01-01
End date: 2011-01-01
Trazodone Hydrochloride
Indication: Product Used FOR Unknown Indication
Start date: 2008-01-01
Unknown Medication
Indication: Product Used FOR Unknown Indication
|
